Lifeward expands board to seven, appoints Robert J. Marshall Jr. as director and Audit Committee chair

Lifeward Ltd.

• Board expanded from six to seven directors, effective November 2, 2024.
• Robert J. Marshall Jr., CFO of Lantheus Holdings (public radiopharmaceutical co.), appointed as Class III director and Audit Committee chair.
• Mr. Marshall previously held senior finance roles at Zimmer Biomet for 16 years; holds CFA designation.
• He qualifies as independent under Nasdaq listing rules; no related party transactions disclosed.
• Director compensation follows standard non-employee director terms per most recent proxy statement.